Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | UCART19 |
Synonyms | |
Therapy Description |
UCART19 are allogeneic T-cells engineered to knockout TCR alpha and CD52, and co-express a chimeric antigen receptor targeting CD19 and Rqr8, which demonstrates anti-tumor activity (J Clin Oncol 33, 2015 (suppl; abstr 3069)). |